Skip to Content

Interferon Alfa-2b

In the US, Interferon Alfa-2b (interferon alfa-2b systemic) is a member of the drug class antineoplastic interferons and is used to treat Angioblastoma, Condylomata Acuminata, Conjunctival Mucosa-Associated Lymphoid Tissue Lymphoma, Follicular Lymphoma, Hairy Cell Leukemia, Hepatitis B, Hepatitis C, Idiopathic Thrombocytopenic Purpura, Kaposi's Sarcoma and Melanoma.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Antineoplastic agent

Antiviral agent: Treatment of hepatitis

Biological response modifier, BRM


Foreign Names

  • Interferonum alfa-2b (Arg-23; His-34) (Latin)
  • Interferon alfa-2b (Arg-23; His-34) (German)
  • Interféron alfa-2b (Arg-23; His-34) (French)
  • Interferón alfa-2b (Arg-23; His-34) (Spanish)

Generic Names

Brand Names

  • Alfaferone
    Alfa Wassermann, Lebanon
  • Alphaferoi
    Akber Brothers, Pakistan
  • An Da Fen
    Anke Biotechnology Group, China
  • An Fu Long
    HuaLiDa Biotechnology, China
  • An Te Fu
    Neptunus, China
  • Anferon
    Atco, Pakistan
  • Bioferon
    Bio Sidus, Thailand; Sidus, Argentina; Instituto Sidus, Lebanon
  • Blauferon-B
    Blausiegel, Brazil
  • Chang Sheng De Jia
    Changchun Institute of Biological Products, China
  • Chang Sheng Fu Kang
    Changchun Institute of Biological Products, China
  • Enduferon
    Heber, Philippines
  • Genferon (Interferon Alfa-2b and Taurine)
    ZAO "BIOKAD", Georgia
  • INF
    Bioprofarma, Argentina
  • Inter 2B
    Delta Farma, Argentina
  • Interferon Alfa 2b Cassara
    Varifarma, Argentina
  • Interferon Alfa-2b
    Biosintetica, Brazil
  • Interferon Alfa-2b Humano Recombinante Bago
    Laboratorio Bago, Chile
  • Interferonas alfa-2b
    Sicor Biotech, Lithuania
  • Interlong
    Neptunus, China
  • Inton A
    Schering-Plough, Bangladesh
  • Intron A
    Bayer Schering, Iran; Merck, Canada; Merck Sharp & Dohme, Australia; Merck Sharp & Dohme, Bosnia & Herzegowina; Merck Sharp & Dohme, Colombia; Merck Sharp & Dohme, Hong Kong; Merck Sharp & Dohme, Croatia (Hrvatska); Merck Sharp & Dohme, New Zealand; Merck Sharp & Dohme, Poland; Merck Sharp & Dohme, Portugal; MSD, Switzerland; MSD, China; MSD, Japan; MSD, Peru; MSD Belgium, Belgium; Schering, United Arab Emirates; Schering, Egypt; Schering, Iraq; Schering, Jordan; Schering, Kuwait; Schering, Qatar; Schering, Saudi Arabia; Schering, United States; Schering, Yemen; Schering-Plough, Bangladesh; Schering-Plough, Bahrain; Schering-Plough, Czech Republic; Schering-Plough, Georgia; Schering-Plough, Hungary; Schering-Plough, Indonesia; Schering-Plough, Israel; Schering-Plough, Lebanon; Schering-Plough, Oman; Schering-Plough, Philippines; Schering-Plough, Romania; Schering-Plough, Serbia; Schering-Plough, Russian Federation; Schering-Plough, Slovakia; Schering-Plough, Syria; Schering-Plough, South Africa
  • Intron A Multi-Dose
    Schering-Plough, Taiwan
  • IntronA
    Merck Sharp & Dohme, Austria; Merck Sharp & Dohme, Chile; Merck Sharp & Dohme, United Kingdom; Merck Sharp & Dohme, Greece; Merck Sharp & Dohme, Iceland; MSD, Denmark; MSD, Finland; MSD, Ireland; MSD, Netherlands; MSD, Norway; MSD, Sweden; MSD France, France; MSD Merck Sharp & Dohme, Germany; Schering-Plough, Italy; Schering-Plough, Lithuania
  • Introna
    Merck Sharp & Dohme, Spain
  • Intron-A
    Merck Sharp & Dohme, Malaysia; MSD Merck Sharp & Dohme, Turkey
  • Kalferon
    Kalbe, Indonesia
  • Longhuanuo
    Binhai Xinbao, China
  • Peg-Intron
    Schering-Plough, Oman
  • Realdiron
    Sicor Biotech, Bulgaria; Sicor Biotech, Lithuania; Sicor Biotech, Latvia; Sicor Biotech, Serbia
  • Refergen
    Sicor Biotech, Lithuania
  • Urifron
    Probiomed, Mexico
  • Urifrón
    Probiomed, Dominican Republic; Probiomed, Guatemala; Probiomed, Honduras; Probiomed, El Salvador
  • Viferon
    Feron, Georgia
  • Viraferon
    Fulford, India
  • Yi Sheng
    Kawin Technologie, China
  • You Ni Long
    Tongyong Tongmeng Pharmaceutical, China


BANBritish Approved Name
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.